000 01528 a2200385 4500
005 20250513095029.0
264 0 _c19960916
008 199609s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/(SICI)1097-0215(19960717)67:2<232::AID-IJC14>3.0.CO;2-D
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThibault, C
245 0 0 _aTumor-infiltrating lymphocytes can be activated in situ by using in vivo activants plus F(ab')2 bispecific antibodies.
_h[electronic resource]
260 _bInternational journal of cancer
_cJul 1996
300 _a232-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bispecific
_xpharmacology
650 0 4 _aCricetinae
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aEnterotoxins
_xpharmacology
650 0 4 _aGlucans
_xpharmacology
650 0 4 _aImmunoglobulin Fab Fragments
_xpharmacology
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aLymphocytes, Tumor-Infiltrating
_ximmunology
650 0 4 _aMelanoma, Experimental
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C3H
650 0 4 _aNeoplasm Transplantation
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
700 1 _aNelson, H
700 1 _aChapoval, A I
773 0 _tInternational journal of cancer
_gvol. 67
_gno. 2
_gp. 232-7
856 4 0 _uhttps://doi.org/10.1002/(SICI)1097-0215(19960717)67:2<232::AID-IJC14>3.0.CO;2-D
_zAvailable from publisher's website
999 _c8757488
_d8757488